Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kwei

Showing results (661-670 of 693) with videos related to

Pageof 70
Sort By:
Plos Genetics|June 7, 2008
Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancerKevin A Kwei, Murali D Bashyam, Jessica Kao, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 18, 2002
The pharmacokinetics of a thiazole benzenesulfonamide beta 3-adrenergic receptor agonist and its analogs in rats, dogs, and monkeys: improving oral bioavailabilityRalph A Stearns, Randy R Miller, Wei Tang, et al.
Bioorganic & Medicinal Chemistry Letters|July 20, 2007
The discovery of potent, selective, and orally bioavailable hNK1 antagonists derived from pyrrolidinePeter Lin, Lehua Chang, Robert J Devita, et al.
Scientific Reports|May 17, 2022
Changing surface ocean circulation caused the local demise of echinoid Scaphechinus mirabilis in Taiwan during the Pleistocene-Holocene transitionSze Ling Ho, Jia-Kang Wang, Yu-Jou Lin, et al.
British Journal of Haematology|February 14, 2018
Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial resultsPaul G Richardson, William I Bensinger, Carol Ann Huff, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 1: Discovery and SAR study of 4-pyrazolylpiperidine side chainsDong-Ming Shen, Min Shu, Sander G Mills, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Stimulation of Glucose-Dependent Insulin Secretion by a Potent, Selective sst3 AntagonistAlexander Pasternak, Zhe Feng, Reynalda de Jesus, et al.
ACS Medicinal Chemistry Letters|November 16, 2018
Discovery and Pharmacology of a Novel Somatostatin Subtype 5 (SSTR5) Antagonist: Synergy with DPP-4 InhibitionWeiguo Liu, Pengcheng P Shao, Gui-Bai Liang, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2006
Cyclopentane-based human NK1 antagonists. Part 2: development of potent, orally active, water-soluble derivativesLaura C Meurer, Paul E Finke, Karen A Owens, et al.
BMC Genomics|March 13, 2016
Integrating RNA-seq and ChIP-seq data to characterize long non-coding RNAs in Drosophila melanogasterMei-Ju May Chen, Li-Kai Chen, Yu-Shing Lai, et al.
Pageof 70

Showing results (661-670 of 693) with videos related to

Sort By:
Pageof 70
Plos Genetics|June 7, 2008
Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancerKevin A Kwei, Murali D Bashyam, Jessica Kao, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 18, 2002
The pharmacokinetics of a thiazole benzenesulfonamide beta 3-adrenergic receptor agonist and its analogs in rats, dogs, and monkeys: improving oral bioavailabilityRalph A Stearns, Randy R Miller, Wei Tang, et al.
Bioorganic & Medicinal Chemistry Letters|July 20, 2007
The discovery of potent, selective, and orally bioavailable hNK1 antagonists derived from pyrrolidinePeter Lin, Lehua Chang, Robert J Devita, et al.
Scientific Reports|May 17, 2022
Changing surface ocean circulation caused the local demise of echinoid Scaphechinus mirabilis in Taiwan during the Pleistocene-Holocene transitionSze Ling Ho, Jia-Kang Wang, Yu-Jou Lin, et al.
British Journal of Haematology|February 14, 2018
Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial resultsPaul G Richardson, William I Bensinger, Carol Ann Huff, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 1: Discovery and SAR study of 4-pyrazolylpiperidine side chainsDong-Ming Shen, Min Shu, Sander G Mills, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Stimulation of Glucose-Dependent Insulin Secretion by a Potent, Selective sst3 AntagonistAlexander Pasternak, Zhe Feng, Reynalda de Jesus, et al.
ACS Medicinal Chemistry Letters|November 16, 2018
Discovery and Pharmacology of a Novel Somatostatin Subtype 5 (SSTR5) Antagonist: Synergy with DPP-4 InhibitionWeiguo Liu, Pengcheng P Shao, Gui-Bai Liang, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2006
Cyclopentane-based human NK1 antagonists. Part 2: development of potent, orally active, water-soluble derivativesLaura C Meurer, Paul E Finke, Karen A Owens, et al.
BMC Genomics|March 13, 2016
Integrating RNA-seq and ChIP-seq data to characterize long non-coding RNAs in Drosophila melanogasterMei-Ju May Chen, Li-Kai Chen, Yu-Shing Lai, et al.
Pageof 70